Management of recurrent or metastatic xervicalxancer Conference Paper


Author: Abu-Rustum, N. R.
Title: Management of recurrent or metastatic xervicalxancer
Conference Title: NCCN 2023 Annual Conference
Abstract: Cervical cancer often affects individuals aged,50 years, with the main cause being a long-lasting infection with certain types of human papillomavirus (HPV). Prevention of cervical cancer includes screening tests and the HPV vaccine and, if found early, it can be treatable. Metastatic disease, however, is more lethal and is a significant problem worldwide due to screening and treatment limitations. Clinicians should discuss early detection options and treatment modalities with patients with cervical cancer for informed decision-making. © JNCCN—Journal of the National Comprehensive Cancer Network.
Keywords: cancer surgery; cancer recurrence; systemic therapy; conference paper; cancer radiotherapy; antineoplastic agent; cancer diagnosis; medical decision making; metastasis; practice guideline; distant metastasis; patient care; uterine cervix cancer; pelvis exenteration; recurrent disease; neuroendocrine carcinoma; papillomavirus infection; human; human papilloma virus vaccine
Journal Title Journal of the National Comprehensive Cancer Network
Volume: 21
Issue: 5.5
Conference Dates: 2023 Mar 31-Apr 2
Conference Location: Orlando, FL
ISBN: 1540-1405
Publisher: Harborside Press  
Date Published: 2023-06-01
Start Page: 576
End Page: 578
Language: English
DOI: 10.6004/jnccn.2023.5013
PROVIDER: scopus
DOI/URL:
Notes: Conference paper -- Meeting also available virtually -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors